Pages that link to "Q36481949"
Jump to navigation
Jump to search
The following pages link to Presenilin-1 280Glu-->Ala mutation alters C-terminal APP processing yielding longer abeta peptides: implications for Alzheimer's disease (Q36481949):
Displaying 10 items.
- Bapineuzumab alters aβ composition: implications for the amyloid cascade hypothesis and anti-amyloid immunotherapy (Q28488690) (← links)
- More than cholesterol transporters: lipoprotein receptors in CNS function and neurodegeneration (Q34557404) (← links)
- The pathogenic aβ43 is enriched in familial and sporadic Alzheimer disease (Q34586360) (← links)
- Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program (Q36121377) (← links)
- Histopathological and molecular heterogeneity among individuals with dementia associated with Presenilin mutations (Q37010838) (← links)
- Subjects harboring presenilin familial Alzheimer's disease mutations exhibit diverse white matter biochemistry alterations (Q37199229) (← links)
- Extracellular vesicles in Alzheimer's disease: friends or foes? Focus on aβ-vesicle interaction (Q38367860) (← links)
- C-Terminal Threonine Reduces Aβ43 Amyloidogenicity Compared with Aβ42. (Q40785358) (← links)
- APP/Aβ structural diversity and Alzheimer's disease pathogenesis (Q46320596) (← links)
- Role of Amyloid Precursor Protein (APP) and Its Derivatives in the Biology and Cell Fate Specification of Neural Stem Cells (Q47703114) (← links)